US authorities on Thursday warned makers of medical devices and hospital networks to step up efforts to guard against potential cyber attacks.
Jun 13, 2013
not rated yet | 0
Gilead Sciences Inc. says that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities.
Apr 29, 2013
1 / 5 (1) | 0